Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease
Clinical and Experimental Immunology Sep 09, 2017
Kusaka S, et al. Â Study authors carried out this investigation to examine LL-37 expression in the inflamed mucosa of inflammatory bowel disease (IBD) patients. They found that LL-37 was induced by TLR3 stimulation and showed an anti-microbial effect via interaction with lipopolysaccharide (LPS).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
